Gordian Biotechnology
@gordianbio.bsky.social
Our mission is to cure age-related disease by moving successful therapeutics toward clinical trials within months, not years. #CreatingTime
Pinned
The success of AI applied to drug discovery is being decided by a number of clinical trials. So far, the results are lackluster. Why? For AI to have a transformational effect in drug discovery, training data must come from living mammals. (🧵1/9)
Reposted by Gordian Biotechnology
Excited to be attending this year's Human genetics and genomics Gordon Research Conference in Portland, ME, where I'll be presenting work from @gordianbio.bsky.social related to our in vivo mosaic screening platform applied to accelerate patient-relevant target discovery in complex diseases!
July 6, 2025 at 6:45 PM
Excited to be attending this year's Human genetics and genomics Gordon Research Conference in Portland, ME, where I'll be presenting work from @gordianbio.bsky.social related to our in vivo mosaic screening platform applied to accelerate patient-relevant target discovery in complex diseases!
This news should instill urgency and remind us to ask ‘why not sooner?’.
@martinbjensen.bsky.social shared a long-term vision for how cures could become abundant, if we believe fast, systematic cure discovery is possible, and build the tools to make it happen.
www.gordian.bio/blog/cures-o...
@martinbjensen.bsky.social shared a long-term vision for how cures could become abundant, if we believe fast, systematic cure discovery is possible, and build the tools to make it happen.
www.gordian.bio/blog/cures-o...
May 16, 2025 at 9:10 PM
This news should instill urgency and remind us to ask ‘why not sooner?’.
@martinbjensen.bsky.social shared a long-term vision for how cures could become abundant, if we believe fast, systematic cure discovery is possible, and build the tools to make it happen.
www.gordian.bio/blog/cures-o...
@martinbjensen.bsky.social shared a long-term vision for how cures could become abundant, if we believe fast, systematic cure discovery is possible, and build the tools to make it happen.
www.gordian.bio/blog/cures-o...
Check out chief science officer @martinbjensen.bsky.social’s post tackling misconceptions about AAV gene therapy only being best suited for rare diseases, and how factors like cost would be very different for common diseases like Parkinson’s, heart failure, and arthritis.
March 25, 2025 at 1:51 PM
Check out chief science officer @martinbjensen.bsky.social’s post tackling misconceptions about AAV gene therapy only being best suited for rare diseases, and how factors like cost would be very different for common diseases like Parkinson’s, heart failure, and arthritis.
Check out vector engineering research associate Chase Bowman performing ultracentrifugation density gradient separation. Not familiar with the process?
March 20, 2025 at 3:00 PM
Check out vector engineering research associate Chase Bowman performing ultracentrifugation density gradient separation. Not familiar with the process?
Last month, we traded the lab for the mountains, heading to Tahoe for a well-earned winter retreat. 🏔️⛷️
As evidenced in the photos, the weather cooperated, and we all were rejuvenated by the gorgeous scenery, time outdoors, and team bonding.
As evidenced in the photos, the weather cooperated, and we all were rejuvenated by the gorgeous scenery, time outdoors, and team bonding.
March 13, 2025 at 3:05 PM
Last month, we traded the lab for the mountains, heading to Tahoe for a well-earned winter retreat. 🏔️⛷️
As evidenced in the photos, the weather cooperated, and we all were rejuvenated by the gorgeous scenery, time outdoors, and team bonding.
As evidenced in the photos, the weather cooperated, and we all were rejuvenated by the gorgeous scenery, time outdoors, and team bonding.
Big (belated) congrats to Alex Araki! 🎉 Formerly a research associate on our in vivo team, Alex defended his thesis & earned a well-deserved promotion to scientist! We’re so proud of him and excited to see all the amazing work he’ll do in this next chapter!
March 6, 2025 at 3:53 PM
Big (belated) congrats to Alex Araki! 🎉 Formerly a research associate on our in vivo team, Alex defended his thesis & earned a well-deserved promotion to scientist! We’re so proud of him and excited to see all the amazing work he’ll do in this next chapter!
ICYMI, co-founders Francisco LePort and @martinbjensen.bsky.social were guests of Dr. Moira Gunn on the BioTech Nation podcast.
It ran on our hometown NPR station KQED and about 200 other @npr.org affiliates.
It ran on our hometown NPR station KQED and about 200 other @npr.org affiliates.
February 3, 2025 at 3:55 PM
ICYMI, co-founders Francisco LePort and @martinbjensen.bsky.social were guests of Dr. Moira Gunn on the BioTech Nation podcast.
It ran on our hometown NPR station KQED and about 200 other @npr.org affiliates.
It ran on our hometown NPR station KQED and about 200 other @npr.org affiliates.
If you don’t already subscribe to the BioTech Nation podcast with Dr. Moira Gunn, you will now!
January 30, 2025 at 5:41 PM
If you don’t already subscribe to the BioTech Nation podcast with Dr. Moira Gunn, you will now!
The success of AI applied to drug discovery is being decided by a number of clinical trials. So far, the results are lackluster. Why? For AI to have a transformational effect in drug discovery, training data must come from living mammals. (🧵1/9)
November 20, 2024 at 2:32 PM
The success of AI applied to drug discovery is being decided by a number of clinical trials. So far, the results are lackluster. Why? For AI to have a transformational effect in drug discovery, training data must come from living mammals. (🧵1/9)